title: The other side: failure in fair and balanced reporting.
authors.forename: Stanley E
authors.initials: SE
authors.lastname: Althof
authors.forename: Irwin
authors.initials: I
authors.lastname: Goldstein
authors.forename: Edgardo
authors.initials: E
authors.lastname: Becher
authors.forename: Annamaria
authors.initials: A
authors.lastname: Giraldi
authors.forename: Yoram
authors.initials: Y
authors.lastname: Vardi
authors.forename: Lorraine
authors.initials: L
authors.lastname: Dennerstein
authors.forename: Lesley
authors.initials: L
authors.lastname: Marson
authors.forename: Lori
authors.initials: L
authors.lastname: Brotto
authors.forename: Patricia
authors.initials: P
authors.lastname: Schreiner-Engel
authors.forename: Kim
authors.initials: K
authors.lastname: Wallen
authors.forename: Anita
authors.initials: A
authors.lastname: Clayton
authors.forename: Alan
authors.initials: A
authors.lastname: Altman
authors.forename: Sheryl
authors.initials: S
authors.lastname: Kingsberg
authors.forename: Ridwan
authors.initials: R
authors.lastname: Shabsigh
mesh_terms: D017277:Drug Approval; D004345:Drug Industry; D005260:Female; D005381:Financing, Organized; D006801:Humans; D008119:Lobbying; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy*; D012955:Societies, Medical; D013739:Testosterone / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D013739:Testosterone